These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 23575829

  • 1. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
    Liot G, Zala D, Pla P, Mottet G, Piel M, Saudou F.
    J Neurosci; 2013 Apr 10; 33(15):6298-309. PubMed ID: 23575829
    [Abstract] [Full Text] [Related]

  • 2. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V, Puigdellívol M, Giralt A, del Toro D, Alberch J, Ginés S.
    Cell Death Dis; 2013 Apr 18; 4(4):e595. PubMed ID: 23598407
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A, Naia L, Dominguez A, Ribeiro M, Rodrigues J, Vieira OV, Lessmann V, Rego AC.
    Neurodegener Dis; 2015 Apr 18; 15(4):207-18. PubMed ID: 25896770
    [Abstract] [Full Text] [Related]

  • 4. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X, Chen XQ, Han E, Hu Y, Paik P, Ding Z, Overman J, Lau AL, Shahmoradian SH, Chiu W, Thompson LM, Wu C, Mobley WC.
    Proc Natl Acad Sci U S A; 2016 Sep 20; 113(38):E5655-64. PubMed ID: 27601642
    [Abstract] [Full Text] [Related]

  • 5. Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice.
    Suelves N, Miguez A, López-Benito S, Barriga GG, Giralt A, Alvarez-Periel E, Arévalo JC, Alberch J, Ginés S, Brito V.
    Mol Neurobiol; 2019 Feb 20; 56(2):935-953. PubMed ID: 29804232
    [Abstract] [Full Text] [Related]

  • 6. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q, Yang J, Li T, Milner TA, Hempstead BL.
    Neurobiol Dis; 2015 Oct 20; 82():466-477. PubMed ID: 26282324
    [Abstract] [Full Text] [Related]

  • 7. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S, Bosch M, Marco S, Gavaldà N, Díaz-Hernández M, Lucas JJ, Canals JM, Alberch J.
    Eur J Neurosci; 2006 Feb 20; 23(3):649-58. PubMed ID: 16487146
    [Abstract] [Full Text] [Related]

  • 8. Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.
    Ginés S, Paoletti P, Alberch J.
    J Biol Chem; 2010 Jul 09; 285(28):21537-48. PubMed ID: 20442398
    [Abstract] [Full Text] [Related]

  • 9. pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking.
    Pardo R, Molina-Calavita M, Poizat G, Keryer G, Humbert S, Saudou F.
    Mol Brain; 2010 Jun 01; 3():17. PubMed ID: 20515468
    [Abstract] [Full Text] [Related]

  • 10. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice.
    Gharami K, Xie Y, An JJ, Tonegawa S, Xu B.
    J Neurochem; 2008 Apr 01; 105(2):369-79. PubMed ID: 18086127
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.
    Xie Y, Hayden MR, Xu B.
    J Neurosci; 2010 Nov 03; 30(44):14708-18. PubMed ID: 21048129
    [Abstract] [Full Text] [Related]

  • 14. JIP3 mediates TrkB axonal anterograde transport and enhances BDNF signaling by directly bridging TrkB with kinesin-1.
    Huang SH, Duan S, Sun T, Wang J, Zhao L, Geng Z, Yan J, Sun HJ, Chen ZY.
    J Neurosci; 2011 Jul 20; 31(29):10602-14. PubMed ID: 21775604
    [Abstract] [Full Text] [Related]

  • 15. Snapin recruits dynein to BDNF-TrkB signaling endosomes for retrograde axonal transport and is essential for dendrite growth of cortical neurons.
    Zhou B, Cai Q, Xie Y, Sheng ZH.
    Cell Rep; 2012 Jul 26; 2(1):42-51. PubMed ID: 22840395
    [Abstract] [Full Text] [Related]

  • 16. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL, Simmons DA, Zuccato C, Illes K, Pallos J, Casale M, Conforti P, Ramos C, Roarke M, Kathuria S, Cattaneo E, Marsh JL, Thompson LM.
    Mol Cell Neurosci; 2008 Sep 26; 39(1):8-20. PubMed ID: 18602275
    [Abstract] [Full Text] [Related]

  • 17. Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington's Disease.
    Yu C, Li CH, Chen S, Yoo H, Qin X, Park H.
    Sci Rep; 2018 Nov 19; 8(1):16976. PubMed ID: 30451892
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.